Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Mar 03, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000054.pdf 0001883850-23-000054.xls
Mar 03, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000053.pdf 0001883850-23-000053.xls
Feb 24, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000050.pdf 0001883850-23-000050.xls
Feb 14, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000048.pdf 0001883850-23-000048.xls
Feb 13, 2023	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001422849-23-000075.pdf 0001422849-23-000075.xls
Feb 09, 2023	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001104659-23-016829.pdf
Feb 09, 2023	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-23-002022.pdf
Feb 08, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000044.pdf 0001883850-23-000044.xls
Feb 08, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000043.pdf 0001883850-23-000043.xls
Feb 08, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000045.pdf 0001883850-23-000045.xls

Data provided by Kaleidoscope.

Investors & Media